Skip to main content
U.S. flag

An official website of the United States government

News and Updates

Bookmark this section to stay up-to-date on events and activities sponsored by Office of AIDS Research (OAR), as well as news articles about OAR from around the web.

Research News

Read news updates on the National Institutes of Health (NIH) HIV/AIDS global research that is conducted by NIH’s Institutes, Centers, and Offices and managed and coordinated by the OAR. This news is extracted from the NIH News Releases page and other sources, which are identified after each news item.

OAR in the News

See important announcements and news from the Office of AIDS Research.

Meetings and Events

Learn about upcoming and past meetings of the Office of AIDS Research Advisory Council (OARAC), World AIDS Day at the NIH, as well as other events coordinated by OAR.

Other NIH News/Announcements

  • NIH at AIDS 2022: The National Institutes of Health (NIH) joins the world's largest gathering on HIV/AIDS at the 24th International AIDS Conference (AIDS 2022). Taking place both online and in person, AIDS 2022 presents an opportunity to showcase HIV research around the globe, innovative approaches to HIV prevention and care, and the U.S. government’s ongoing commitment to ending HIV at home and abroad. Use these resources from the NIH to communicate activities at AIDS 2022.
  • NIH OAR statement on monkeypox: The National Institutes of Health (NIH) Office of AIDS Research (OAR) supports the position of the Centers for Disease Control and Prevention (CDC), HHS Office of Infectious Disease and HIV/AIDS Policy (OIDP), and the White House Office of National AIDS Policy (ONAP) to emphasize the importance of non-stigmatizing language and practices to ensure equitable and responsive public health action related to the monkeypox outbreak in the United States and globally. The NIH OAR reiterates that anyone with exposure to monkeypox virus can become infected in the United States or abroad, regardless of sexual orientation or gender identity. For persons with HIV or at risk of HIV acquisition, the initiation and adherence to antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) are critical, regardless of monkeypox virus exposure.
  • How Cancer Research Led to AIDS Breakthroughs: The National Cancer Institute (NCI) has played a vital role in the field of HIV/AIDS since the early 1980s when the syndrome of diseases later named AIDS was first identified. This article, published by the NCI Office of HIV and AIDS Malignancy, shows how the National Cancer Act and NCI’s work paved the way for the resources, skills, and expertise to be in place for those at the forefront of HIV/AIDS research.
  • Funding Opportunity Announcement PAR-20-224:  Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional)
    The NIDA Avenir Award Program provides grants to early-stage investigators who propose potentially transformative studies in substance use and HIV. Applications due 8/13. Letter of intent due date is 30 days prior to the application due date.
  • Funding Opportunity Announcement PAR-21-238
    This Funding Opportunity Announcement (FOA) invites applications from qualified research institutions to seek funds to develop or renovate research facilities that support HIV/AIDS research in areas of basic, translational, clinical, and social and behavioral science research. Targeted are institutions that serve underrepresented and underserved populations or that are in Institutional Development Award (IDeA)-eligible states. Research-intensive institutions are not eligible. The facilities must support research aligned with the NIH-established priorities for HIV/AIDS research. Any request must be justified by current and anticipated future research needs. Applications are due by January 6, 2022.
  • On World AIDS Day, Celebrating Scientific Advances and Confronting the Complexities of HIV and Substance Use: By Dr. Nora Volkow, November 30, 2020

This page last reviewed on January 27, 2023